22nd Century Cash Flow from Operating Activities 2011-2023 | XXII
22nd Century cash flow from operating activities from 2011 to 2023. Cash flow from operating activities can be defined as a company's cash flows from operations.
22nd Century Annual Cash Flow Ops (Millions of US $) |
2023 |
$-55 |
2022 |
$-52 |
2021 |
$-23 |
2020 |
$-16 |
2019 |
$-15 |
2018 |
$-18 |
2017 |
$-12 |
2016 |
$-10 |
2015 |
$-7 |
2014 |
$-7 |
2013 |
$4 |
2012 |
$-2 |
2011 |
$-3 |
2010 |
$-1 |
Sector |
Industry |
Market Cap |
Revenue |
Consumer Staples |
Tobacco Products |
$0.012B |
$0.032B |
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|